Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers completes initial Medarex offer
Yahoo/AP
Thursday, August 27, 2009 - 9:34am
tags:
Medarex, Bristol-Myers Squibb, M&A
Abbott, Pfizer in pact for lung cancer screening
CNBC
Thursday, August 27, 2009 - 9:32am
tags:
lung cancer, Pfizer, Abbott Laboratories, partnerships
UCB, Immunomedics drug shows promise for lupus
Reuters
Thursday, August 27, 2009 - 9:17am
tags:
UCB Pharmaceuticals, Immunomedics, lupus
BioDelivery Sciences Can Now Be Considered a Long Term Growth Stock
Seeking Alpha
Thursday, August 27, 2009 - 9:17am
tags:
BioDelivery Sciences
Cell Therapeutics Could Be a Real Winner, But Not Right Now
Seeking Alpha
Thursday, August 27, 2009 - 8:30am
tags:
Cell Therapeutics, cancer
Geron Comments on FDA Hold on Spinal Cord Injury Trial
Yahoo
Thursday, August 27, 2009 - 8:17am
tags:
Geron, FDA, drug trials
Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Yahoo/AP
Thursday, August 27, 2009 - 8:16am
tags:
Alkermes, JNJ, Risperdal Consta, antipsychotics
Don't Bury Ariad's Patent Yet
Seeking Alpha
Thursday, August 27, 2009 - 8:14am
tags:
Ariad Pharmaceuticals, Eli Lilly, patents
Bayer Falls as Boehringer’s Pradaxa Seen Challenging Xarelto
Bloomberg
Thursday, August 27, 2009 - 7:40am
tags:
Bayer, Boehringer Ingelheim, blood thinners, Xarelto
Bristol-Myers' Orencia: Small Change, Big Impact?
Motley Fool
Thursday, August 27, 2009 - 7:38am
tags:
Orencia, Bristol-Myers Squibb
Biogen granted more time in drug dispute with Elan
Irish Independent
Wednesday, August 26, 2009 - 7:51pm
tags:
Biogen Idec, Elan, Tysabri
J&J warns of allergic reactions with HIV drug
Yahoo/AP
Wednesday, August 26, 2009 - 7:49pm
tags:
JNJ, HIV, FDA, Intelence
GSK seems to dismiss HGS rumour
FT.com
Wednesday, August 26, 2009 - 5:43pm
tags:
GSK, Human Genome Sciences, M&A
How to Play the Viropharma Buyout
Minyanville
Wednesday, August 26, 2009 - 5:42pm
tags:
ViroPharma, buyouts, Teva Pharmaceuticals
Amgen Falls Back on the Future
Motley Fool
Wednesday, August 26, 2009 - 5:41pm
tags:
Amgen, Aranesp
ISTA's Eye Drug Shows Success
Yahoo/Zacks.com
Wednesday, August 26, 2009 - 5:40pm
tags:
Ista, Alcon, Allergan, Xibrom
Schering-Plough asthma drug, oral contraceptive being reviewed by European regulators
Yahoo/AP
Wednesday, August 26, 2009 - 4:49pm
tags:
Schering Plough, asthma, contraceptives, EU, Europe
Boehringer Ingelheim Axes 600-900 Drug Sales Reps
BNET Pharma
Wednesday, August 26, 2009 - 3:44pm
tags:
Boehringer Ingelheim, layoffs
Merck says European Union agrees to review intravenous version of heart drug vernakalant
Yahoo/AP
Wednesday, August 26, 2009 - 3:42pm
tags:
Merck, EU, European, Vernakalant
J&J consolidating management, starting by eliminating new comprehensive care business unit
Yahoo/AP
Wednesday, August 26, 2009 - 10:34am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.